Stanford University


Showing 4,151-4,200 of 13,016 Results

  • Laura Michele Hack

    Laura Michele Hack

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Laura M. Hack is an Assistant of Psychiatry and Behavioral Sciences at Stanford University and the Veterans Affairs Palo Alto Health Care System (PAVAHCS). As Associate Director of the Novel & Precision Neurotherapeutics Program at the Stanford Center for Precision Mental Health, Dr. Hack leads a translational, patient-centered research group that designs and implements mechanistic clinical trials for biologically informed subtypes of Mood, Anxiety, and Trauma-related Disorders (MATRDs).

    Her work spans repurposed pharmacologic interventions (e.g., guanfacine), neuromodulation techniques (e.g., repetitive transcranial magnetic stimulation [TMS]), and therapies involving altered states of consciousness (i.e., ketamine, MDMA, psilocybin, and anesthesia-induced dreaming). Across these modalities, Dr. Hack's focus is on tailoring treatment based on objective, biologically anchored markers that match the patient’s profile.

    Dr. Hack also directs the Stanford Precision Psychiatry Clinic, a high-touch, high-tech consultation service designed to support individuals with a primary diagnosis of major depression and often comorbid MATRDs. This clinic integrates the investigational use of high-definition neuroimaging (personalized brain circuit scores) with symptom profiling, neurocognitive testing, pharmacogenomic analysis, inflammatory biomarkers, and standard blood work. The aim is to generate individualized insights that inform treatment decisions and help patients better understand the biological underpinnings of their condition—often reducing self-blame and empowering engagement in care.

    In her role as Deputy Director as well as Ketamine and Education Lead of the Precision Neuromodulation Clinic (PNC) at PAVAHCS, Dr. Hack specializes in delivering evidence-based, FDA-cleared interventions including TMS and intranasal ketamine for Veterans experiencing treatment-resistant depression, frequently in the context of comorbid PTSD.

  • Francois Haddad

    Francois Haddad

    Clinical Professor, Medicine - Cardiovascular Medicine

    BioDr. Francois Haddad, MD is a Clinical Professor of Medicine that specializes in the field of cardio-vascular imaging, pulmonary hypertension, advanced heart failure and transplantation. Dr. Haddad has over 18 years of practice in the field of cardiology. He directs Stanford Cardiovascular Institute Biomarker and Phenotypic Core Laboratory dedicated to translational studies in cardiovascular medicine. The laboratory focuses on (1) identifying early biomarkers of heart failure and aging, (2) bioengineering approaches to cardiovascular disease modeling and (3) novel informatic approach for the detection and risk stratification of disease. He is involved is several precision medicine initiatives in health including the Project Baseline, the Integrated Personalized Omics Profiling Initiative, the Athletic screening program at Stanford and the Strong-D cardiac rehabilitation initiative in individuals with diabetes mellitus.

  • Lindsey Merrihew Haddock

    Lindsey Merrihew Haddock

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioLindsey Haddock, MD, MAEd, is a geriatrician and clinician-educator with a master's degree in education. She is the Vice Chief for Education in Primary Care and Population Health. She is an Educator-4-CARE faculty in the School of Medicine, serving as a longitudinal teacher and mentor for medical students, and also precepts students in the ambulatory medicine clerkship. She works clinically in Stanford Senior Care Clinic and the inpatient geriatrics service.

    Dr. Haddock is an award-winning educator whose mission is to foster an inclusive, humanistic learning environment and help students, trainees, and faculty recognize, elevate, and share the value of their educational work. Her academic interests in education include learning in the clinical workplace, evaluation of workplace based assessments, and patient and family engaged medical education.

  • Christiane Haeffele

    Christiane Haeffele

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsAdult Congenital Heart Disease

  • Jen Haensel

    Jen Haensel

    Basic Life Res Scientist, Ophthalmology Research/Clinical Trials

    BioI am a Research Scientist in the Roberts Vision Development & Oculomotor Lab at Stanford University’s Department of Ophthalmology, working at the intersection of vision science, neuroscience, and experimental psychology. My current research uses eye-tracking, photorefraction, and psychophysics to study oculomotor development and visual function in amblyopia, strabismus, and concussion. I also work on developing methodology to record accommodative measurements and gaze behaviour in dynamic, naturalistic settings.

    I completed my PhD in Experimental Psychology at Birkbeck, University of London (UK), where I used advanced eye-tracking techniques to study the influence of postnatal experience on social gaze behaviour. Prior to joining Stanford, I also worked as a postdoctoral researcher at the University of Bath (UK), developing empirical human-robot interaction studies to inform the ethical design of humanoid robots.

  • Kurt M. Hafer, MD, FACP

    Kurt M. Hafer, MD, FACP

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioDr. Kurt Hafer is a board-certified physician and Fellow of the American College of Physicians (FACP) practicing Primary Care Internal Medicine exclusively at Stanford Concierge Medicine.

    Dr. Hafer grew up in Chapel Hill, NC and attended Pomona College, where he received his undergraduate degree in Psychology. After completing post-baccalaureate pre-medical coursework at the University of Michigan (UM) in Ann Arbor, he worked as a neuro-endocrine peptide researcher at UM.

    In 1999, Dr. Hafer graduated from The University of Chicago Pritzker School of Medicine. He completed a Primary Care Internal Medicine Residency at Santa Clara Valley Medical Center (SCVMC) in San Jose in 2002. Between 2002 to 2012 he was a Teaching Attending Physician at SCVMC as well as an adjunct Stanford physician, training medical students and residents in Internal Medicine.

    Dr. Hafer joined Stanford in 2012 as the founding Medical Director of the Stanford Primary Care, Portola Valley Clinic -- Stanford's first new primary care clinic in many years. His five years of leadership at the Portola clinic included incorporating the latest technologies into primary care, adopting active population health panel management, LEAN management practices, embedded specialists and evidence-based, best-care practices as a viable model for the future of Stanford Primary Care.

    In January 2017, Dr. Hafer joined Stanford Concierge Medicine as Medical Director. In addition to caring for his patients, his duties include directing the clinic and expanding clinic offerings in mental health, wellness, and piloting Primary Care Genetics and Pharmacogenomics screening programs as a test bed for Stanford Primary Care.

    While at Stanford, Dr. Hafer has served as a lecturer for the American College of Physician's Internal Medicine Maintenance of Certification Course held in San Francisco, and has been a Reviewer for the American College of Physicians on multiple projects. He has served on numerous Stanford Healthcare committees and worked with teams on numerous projects, including Stanford's Primary Care 2.0 Redesign, Hypertension Center of Excellence Clinical Integration Team, The Virtual Hypertension Monitoring Project, and Stanford's Primary Care Precision Health program design team. He has directed pilots of TeleHealth phone and video visits, integration of specialty care MDs into our primary care clinics. He led a successful Clinical Effectiveness Leadership Training (CELT) project using clinical pharmacists embedded in primary care clinics to more effectively manage diabetes and high blood pressure between MD visits. He has also served as the Physician Leader for Stanford's Realizing Improvement through Team Empowerment (RITE) Quality Improvement Program.

    He currently serves as a Physician Member and Chair (2023, 2024) of the Global Executive Services (GES) Network Steering Committee, part of the Vizient University Health System Consortium, a national group of ~200 members of academic medical centers with Executive Health or Concierge Medicine services.

    When not caring for patients, Dr. Hafer enjoys spending time outdoors with family and friends. He is married to a Stanford University History Professor, has a daughter who graduated from Stanford and UCLA Medical School (now a resident at UCSF), as well as a son who completed a masters degree in computer science at Stanford. He is an avid lifelong cyclist (road and MTB, logging up to 8k miles annually), hiker, has a passion for tinkering with vintage Datsuns and enjoys wearing vintage watches.

    Dr. Hafer believes that a combination of truly knowing his patients as individuals, excellent patient-physician communication, and comprehensive preventive care allows him to provide exceptional care for his patients.

  • Jennifer Hah

    Jennifer Hah

    Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)

    Current Research and Scholarly InterestsPerioperative Recovery of Opioids Mood and Pain Trial

  • Jin S. Hahn, MD

    Jin S. Hahn, MD

    Professor of Neurology at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests1. Clinical informatics and electronic health records
    2. Neonatal and fetal neurology
    3. Prenatal diagnosis neurodevelopmental anomalies
    4. Personalized Health and Wellness Records

  • Bereketeab Haileselassie

    Bereketeab Haileselassie

    Associate Professor of Pediatrics (Critical Care)

    Current Research and Scholarly InterestsMy laboratory is focused on understanding the cellular mechanisms which mediate end-organ failure in pediatric sepsis. Our current work focuses on determining the role of altered mitochondrial dynamics in sepsis-induced multi-organ dysfunction syndrome (MODS). Specifically, we focus on understanding the mechanisms that mediate derangements in mitochondrial fission and autophagy in sepsis.

  • Jens Hainmueller

    Jens Hainmueller

    Kimberly Glenn Professor and Professor of Political Science

    BioJens Hainmueller is the Kimberly Glenn Professor of Political Science. He co-directs the Stanford Immigration Policy Lab and is a Faculty Affiliate at the Stanford Center for Causal Science, the Institute for Human-Centered Artificial Intelligence, and the Europe Center. He is also a member of the Maternal & Child Health Research Institute at Stanford’s School of Medicine.

    Hainmueller’s research spans statistical methods, causal inference, immigration, and political economy, and he has published nearly 70 articles with over 40,000 citations. Many of his works appear in top journals, including Science, Nature, and PNAS, as well as leading field journals in political science, statistics, economics, and business.

    He has developed widely adopted statistical methods—such as synthetic control methods, entropy balancing, Average Marginal Component Effects, and GeoMatch algorithms—and created several open-source software packages that support empirical research across disciplines. At Stanford, he teaches courses on causal inference and data science.

    Hainmueller’s contributions have earned him prestigious awards, including the Gosnell Prize for Excellence in Political Methodology, the Warren Miller Prize, the Robert H. Durr Award, and the Emerging Scholar Award from the Society of Political Methodology. He is an Andrew Carnegie Fellow, an elected Fellow of the Society of Political Methodology, and holds an honorary degree from the European University Institute (EUI).

    He earned his PhD from Harvard University, with additional studies at the London School of Economics, Brown University, and the University of Tuebingen. Before joining Stanford, he was a faculty member at the Massachusetts Institute of Technology (MIT).

    For a full list of his publications, please refer to his Google Scholar Citation Page and CV.

  • Thomas Hainmueller, MD, PhD

    Thomas Hainmueller, MD, PhD

    Instructor, Psychiatry and Behavioral Sciences

    BioDr. Thomas Hainmueller is a board-certified, fellowship-trained interventional psychiatrist with Stanford Health Care. He is an instructor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.

    He diagnoses and treats a range of behavioral health conditions, including depression, anxiety disorders, obsessive-compulsive disorder (OCD), and disorders at the intersection of neurology and psychiatry.

    Dr. Hainmueller is an expert in various neuromodulation treatments, including deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), and vagal nerve stimulation (VNS). He also specializes in rapid-acting medication approaches, such as ketamine, as well as traditional psychiatric medications. He partners with patients to develop individualized treatment plans that focus on their unique needs and preferences.

    Dr. Hainmueller’s approach is informed by his background in circuit neuroscience research. This branch of neuroscience studies how the brain uses networks of neurons and circuits to process information. Building on a background in neuronal circuits supporting emotions and memory, he investigates the effects of DBS and other neuromodulation treatments on mood and anxiety disorders. His active research projects span preclinical mechanistic studies of neuronal circuit function to innovative clinical protocols for DBS.

    His research findings have been published in Nature, Science, Neuron, and other peer-reviewed journals. Dr. Hainmueller has presented to his peers at international and national meetings, including the annual meetings of the American College of Neuropsychopharmacology and Society for Neuroscience.

    He serves as an invited ad hoc reviewer for several editorial boards, including Science, Proceedings of the National Academy of Sciences, the American Journal of Psychiatry, Nature Communications, and the Journal of Neuroscience.

    Dr. Hainmueller is a member of the American Psychiatric Association and the Society for Neuroscience.

  • belal hakim

    belal hakim

    Clinical Assistant Professor (Affiliated), Medicine - Med/Nephrology

    BioBelal grew up in Fremont and later lived in Singapore where he completed his secondary education. He received his bachelors in Biological Psychology and then his medical degree from Tufts University. He completed his internal medicine and chief residency at Santa Clara Valley Medical Center which solidified his interest in care for the medically underserved. His current research interests include improving diuretic management in advanced CKD and hemodialysis as well as CKD care for underserved communities

  • Michael Halaas

    Michael Halaas

    Associate Dean and Chief Operating Officer, SoM, Chief Operating Officer - Operations

    Current Role at StanfordIn my role as Chief Operating Officer and Associate Dean, I provide oversight and strategic leadership of the operations of the School of Medicine. This includes developing and leading the execution of major strategic initiatives and ensuring foundational operations are rigorous and effectively support the tripartite missions of Education, Research and Patient Care. I am a member of the Dean's leadership team and a representative of the School of Medicine in a variety of forums throughout Stanford and externally

    I also co-lead the Stanford Medicine Catalyst program with Dr. Euan Ashley. We focus on discovering, supporting and propelling healthcare innovation from within the Stanford community. When these innovations are ready, we assist in the commercialization and scaling to reach maximum impact and improve human health. https://smcatalyst.stanford.edu

    The combination of these roles provides a unique opportunity to work at the forefront of transformative health innovation and the operations of complex academic medical center ecosystem.

  • Lou Halamek

    Lou Halamek

    Professor of Pediatrics (Neonatology) and, by courtesy, of Obstetrics and Gynecology

    Current Research and Scholarly Interests1. development of hospital operations centers coupled with sophisticated simulation capabilities
    2. re-creation of near misses and adverse events
    3. optimizing human and system performance during resuscitation
    4. optimizing pattern recognition and situational awareness at the bedside
    5. evaluation and optimization of debriefing
    6. patient simulator design

  • Ashley Eileen Halkett

    Ashley Eileen Halkett

    Social Science Research Professional 3, Pediatrics - Adolescent Medicine

    Current Role at StanfordSocial science researcher in the Division of Adolescent Medicine. Lecturer for undergraduate Adolescent Health and Development course, Program in Human Biology (Autumn 2025).

  • Heather Kenna Hall

    Heather Kenna Hall

    Director of Faculty Affairs & Strategic Planning, Psychiatry and Behavioral Sciences

    BioHeather has been part of the Department of Psychiatry and Behavioral Sciences at Stanford since 2002. She directly manages appointment matters related to Professoriate faculty and supervises a team of faculty affairs administrators who manage appointment matters for faculty on the Clinician Educator line and other faculty appointment lines in the Department. Further responsibilities include supervision of medical education team members and contributions to strategic planning and development of new departmental initiatives. Prior to her current work in faculty affairs, Heather was as a clinical research manager in the Stanford Depression Research Center and the Stanford Women’s Wellness Clinic. She has published 40+ research articles in psychiatry and neuroscience journals. Her education includes a Master of Science in Psychology, as well as a Master of Arts in Social Psychology.

  • Karen Thomson Hall

    Karen Thomson Hall

    Associate Director of CISL, Standardized Patient Program, Immersive and Simulation-based Learning

    Current Role at StanfordInterim Director, Center for Immersive and Simulation-based Learning (CISL)
    Director, Standardized Patient Program
    Goodman Immersive Learning Center
    Li Ka Shing Center for Learning and Knowledge

  • Mason (Max) Alexander Hall

    Mason (Max) Alexander Hall

    Affiliate, Enterprise Strategy

    BioMedical student at Alice L. Walton School of Medicine
    University of Alabama Alumnus

  • Scott S. Hall, Ph.D

    Scott S. Hall, Ph.D

    Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)

    Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.

  • Haijing Wu Hallenbeck, PhD

    Haijing Wu Hallenbeck, PhD

    Affiliate, Psych/Public Mental Health & Population Sciences

    BioHaijing Hallenbeck, PhD, is a research investigator at the National Center for PTSD Dissemination & Training Division at VA Palo Alto Health Care System. She is also an Instructor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She received her PhD in Clinical Psychology from Washington University in St. Louis and completed her predoctoral clinical internship and postdoctoral research fellowship at VA Palo Alto Health Care System. Funded by VA Career Development Awards, Dr. Hallenbeck's research focuses on PTSD and depression and their impact on psychosocial functioning. She studies how to leverage digital health technology (e.g., mobile apps) and analytic tools (e.g., network analysis) to provide timely and personalized assessments and interventions.

    Email: haijing.hallenbeck@stanford.edu

  • James Hallenbeck, MD

    James Hallenbeck, MD

    Associate Professor of Medicine (Primary Care and Population Health) at the Palo Alto Veterans Affairs Health Care System, Emeritus

    Current Research and Scholarly InterestsResearch in hospice and palliative care with emphases on physician education, cultural aspects of end-of-life care, and healthcare system issues.

  • Meghan Halley

    Meghan Halley

    Member, Maternal & Child Health Research Institute (MCHRI)

    BioMeghan Halley, PhD, MPH is Assistant Professor of Pediatrics (Research) in the Center for Biomedical Ethics at Stanford University School of Medicine. With training in medical anthropology, public health and health services research, her scholarship draws on multidisciplinary theoretical and methodological approaches to examine ethical, legal, social and policy questions arising in clinical and translational research. Her areas of expertise include the ethics of new genomic technologies, normative frameworks for integrating research and clinical care, challenges and opportunities in patient and community engagement, and the epistemic and ethical implications of valuing new health interventions. Her work has been funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, and the National Science Foundation and published in high-impact journals including the New England Journal of Medicine, Nature Genetics, and the American Journal of Bioethics.

  • Joachim Hallmayer

    Joachim Hallmayer

    Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development), Emeritus

    Current Research and Scholarly InterestsPrincipal Investigator
    Infrastructure to facilitate discovery of autism genes
    The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
    accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.

    Principal Investigator
    A California Population-Based Twin Study of Autism
    This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?

    Co-Investigator
    Center for Integrating Ethics in Genetics Research(Cho)
    The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.

    Co-Investigator
    Gene, Brain and Behavior in Turner Syndrome(Reiss)
    The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.

    Project Director
    Project F: Genomic Analysis in narcolepsy cataplexy
    The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families.